AstraZeneca notches win in ongoing 340B legal fight
Healthcare
Stay updated with breaking news from Maureen Testoni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abigail Spanberger is leading a bipartisan effort to protect the 340B Drug Pricing Program.
Bristol Myers Squibb will become the 12th drugmaker to restrict 340B discounts after it signaled its intent to limit such discounts for safety net hospitals' contract pharmacies, according to a recent letter the company sent out to hospitals. The policy is set to begin in March, at which point new access restrictions will be placed on all drugs other than the company's
Drug company AbbVie has told safety-net hospitals it will stop offering 340B drug pricing program discounts on drugs dispensed at community-based pharmacies starting Feb. 1, if the hospitals do not agree to turn over patient claims data for those pharmacies to the company.